Insights
Search Results
Client Highlights
4.17.26
Firm Advises Neurona Therapeutics on Acquisition by UCB
On April 17, 2026, UCB, a global biopharmaceutical company, announced that it has entered into a definitive agreement under which UCB would acquire Neurona Therapeutics, including lead asset NRTX-1001, adding to UCB’s epilepsy portfolio. Neurona Therapeutics is a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for epilepsies and other disorders of the nervous system. Under the terms of the agreement, UCB will pay $650 million upfront and up to $500 million in potential future milestone payments, subject to certain closing conditions. Wilson Sonsini Goodrich & Rosati advised Neurona on the transaction.
Client Highlights
4.08.26
Wilson Sonsini Advises Sportsbox on Acquisition by Investor Group Led by Bryson DeChambeau
On April 7, 2026, a group of investors led by professional golfer Bryson DeChambeau announced its acquisition of Sportsbox AI, a leader in kinematic AI technology and 3D motion capture for coaching and training across mobile sports and fitness applications. Wilson Sonsini Goodrich & Rosati advised Sportsbox on the transaction.
Client Highlights
12.08.25
Wilson Sonsini Advises Foresight Diagnostics on Acquisition by Natera
On December 5, 2025, Natera, Inc., a global leader in cell-free DNA and precision medicine, and Foresight Diagnostics, a leader in ultrasensitive molecular residual disease (MRD) detection, announced that Natera has completed its acquisition of Foresight in an all-stock transaction consisting of a $275 million upfront payment with an additional $175 million in earnouts tied to the achievement of revenue- and reimbursement-based milestones. Wilson Sonsini Goodrich & Rosati advised Foresight on the transaction.
The transaction combines Natera’s leading commercial and operational infrastructure for the delivery of personalized MRD testing with Foresight’s unique phased variant technology and leadership in lymphoma. It builds on Natera’s broad intellectual property portfolio for tumor-informed and personalized MRD products including in phased variants, and promises to accelerate MRD adoption in lymphoma and other solid tumor types.
The transaction combines Natera’s leading commercial and operational infrastructure for the delivery of personalized MRD testing with Foresight’s unique phased variant technology and leadership in lymphoma. It builds on Natera’s broad intellectual property portfolio for tumor-informed and personalized MRD products including in phased variants, and promises to accelerate MRD adoption in lymphoma and other solid tumor types.
Client Highlights
12.03.25
Wilson Sonsini Advises Serent Capital on Recapitalization and Exit from Axiom Medical
On December 3, 2025, Serent Capital, a growth-focused private equity firm, announced the successful recapitalization of Axiom Medical, a leading provider of technology-enabled workplace injury management and employee health solutions. After a seven-year partnership with Serent Capital, Axiom Medical has received a strategic growth investment from NMS Capital to support its next phase of expansion. Wilson Sonsini Goodrich & Rosati advised Serent Capital on the transaction.
The Wilson Sonsini team that advised Serent Capital on the transaction included:
M&A
Rob Ishii
Catherine Riley Tzipori
David Adler
Elia Perez Villamarin
Yifeng Li
Eric Conner
Tax
Jonathan Zhu
Derek Wallace
Han Shen
Antitrust and Competition
Ben Labow
Kimberley Biagioli
Julio Albornoz
Technology Transactions
Barath Chari
Morgan Kasenchak
Brittany Von Rueden
Stephanie Stark
Employee Benefits and Compensation
Sriram Krishnamurthy
Matthew Norgard
Madeleine Boshart
Jason Chan
Laura Yun
Employment
Nedim Novakovic
Data, Privacy, and Cybersecurity
Matt Staples
Daniel Chen
Chany Kim
Regulatory
Jodi Daniel
Andrea Linna
Nawa Lodin
For more information, please see Serent’s news release.
The Wilson Sonsini team that advised Serent Capital on the transaction included:
M&A
Rob Ishii
Catherine Riley Tzipori
David Adler
Elia Perez Villamarin
Yifeng Li
Eric Conner
Tax
Jonathan Zhu
Derek Wallace
Han Shen
Antitrust and Competition
Ben Labow
Kimberley Biagioli
Julio Albornoz
Technology Transactions
Barath Chari
Morgan Kasenchak
Brittany Von Rueden
Stephanie Stark
Employee Benefits and Compensation
Sriram Krishnamurthy
Matthew Norgard
Madeleine Boshart
Jason Chan
Laura Yun
Employment
Nedim Novakovic
Data, Privacy, and Cybersecurity
Matt Staples
Daniel Chen
Chany Kim
Regulatory
Jodi Daniel
Andrea Linna
Nawa Lodin
For more information, please see Serent’s news release.
Client Highlights
7.22.25
Wilson Sonsini Advises dYdX on its Acquisition of Pocket Protector
On July 18, 2025, dYdX, a decentralized derivatives exchange, announced its recent acquisition of Pocket Protector, a crypto social trading platform. The acquisition includes Pocket Protector’s products joining the dYdX product suite and brings Pocket Protector’s engineering team to dYdX. With this recent addition, dYdX plans to expand into new forms of trading and integrate social features into its core products. Wilson Sonsini Goodrich & Rosati advised dYdX on the transaction.
Client Highlights
6.06.25
Firm Advises IonQ on Acquisition of Lightsynq Technologies
On May 30, 2025, IonQ, a leading commercial quantum computing and networking company, completed its acquisition of Lightsynq Technologies Inc., a Boston-based startup founded by former Harvard University quantum memory experts. The addition of Lightsynq’s team and intellectual property is expected to significantly accelerate IonQ’s quantum networking and quantum computing roadmaps. Wilson Sonsini Goodrich & Rosati advised IonQ on the transaction.
Client Highlights
5.08.25
Firm Advises IonQ on Agreement to Acquire Lightsynq Technologies
On May 7, 2025, IonQ, a leading commercial quantum computing and networking company, announced that it has entered into a definitive agreement to acquire Lightsynq Technologies Inc., a Boston-based start-up founded by former Harvard University quantum memory experts. Lightsynq’s team and IP are expected to significantly accelerate both IonQ’s quantum networking and quantum computing roadmaps. Wilson Sonsini Goodrich & Rosati is advising IonQ on the transaction.
Lightsynq was founded by former Harvard quantum networking experts and Amazon Web Services (AWS) Center for Quantum Networking leaders Dr. Mihir Bhaskar (CEO), Dr. Bart Machielse (CTO), and Dr. David Levonian (CPO) with the goal of building the leading photonic interconnect platform to enable high-fidelity, multi-nodal qubit operations. Lightsynq’s approach not only supports modular scalability, but also advances fault-tolerance for creating the world’s most powerful interconnected quantum systems. Lightsynq’s unique architecture provides a powerful platform to support IonQ’s quantum computers and advance the company’s quantum networking roadmap.
IonQ will also acquire ownership of Lightsynq’s portfolio of over 20 technology patents and patent applications related to quantum memory, further strengthening IonQ’s growing intellectual property position.
The Wilson Sonsini team advising IonQ on the acquisition includes:
M&A
Rich Mullen
Brian Chan
Hallee Moore
Elia Perez Villamarin
Austin Wolfe
Melis Kilic
Matt Katona
Lightsynq was founded by former Harvard quantum networking experts and Amazon Web Services (AWS) Center for Quantum Networking leaders Dr. Mihir Bhaskar (CEO), Dr. Bart Machielse (CTO), and Dr. David Levonian (CPO) with the goal of building the leading photonic interconnect platform to enable high-fidelity, multi-nodal qubit operations. Lightsynq’s approach not only supports modular scalability, but also advances fault-tolerance for creating the world’s most powerful interconnected quantum systems. Lightsynq’s unique architecture provides a powerful platform to support IonQ’s quantum computers and advance the company’s quantum networking roadmap.
IonQ will also acquire ownership of Lightsynq’s portfolio of over 20 technology patents and patent applications related to quantum memory, further strengthening IonQ’s growing intellectual property position.
The Wilson Sonsini team advising IonQ on the acquisition includes:
M&A
Rich Mullen
Brian Chan
Hallee Moore
Elia Perez Villamarin
Austin Wolfe
Melis Kilic
Matt Katona
Client Highlights
4.02.25
Wilson Sonsini Advises LinkedIn on Transaction with Tumult Labs
On March 31, 2025, LinkedIn and Tumult Labs announced a transaction that brings to LinkedIn the Tumult Labs team, which has deep expertise in differential privacy and algorithmic fairness that can be harnessed in building responsible AI solutions. Wilson Sonsini Goodrich & Rosati advised LinkedIn on the transaction.
Client Highlights
10.25.24
Wilson Sonsini Advises Socure on $136 Million Acquisition of Effectiv
On October 24, 2024, Socure, the leading provider of artificial intelligence for digital identity verification, fraud prevention, and sanction screening, announced that it has signed an agreement to acquire Effectiv, a real-time risk decisioning company, for $136 million. Wilson Sonsini Goodrich & Rosati advised Socure on the transaction.
The strategic acquisition pairs Socure’s best-in-class digital identity verification and fraud solutions with a developer-friendly AI orchestration and decisions platform. With this acquisition, Socure—which serves more than 2,700 customers and has verified more than 2.26 billion identities over the past 12 months—further solidifies its leadership position in the identity verification and fraud prevention market, and is propelled into the $200 billion enterprise fraud industry, which additionally encompasses payments fraud, credit underwriting, and AML transaction monitoring. The transaction is expected to close in November.
The Wilson Sonsini team that advised Socure on the transaction includes:
The strategic acquisition pairs Socure’s best-in-class digital identity verification and fraud solutions with a developer-friendly AI orchestration and decisions platform. With this acquisition, Socure—which serves more than 2,700 customers and has verified more than 2.26 billion identities over the past 12 months—further solidifies its leadership position in the identity verification and fraud prevention market, and is propelled into the $200 billion enterprise fraud industry, which additionally encompasses payments fraud, credit underwriting, and AML transaction monitoring. The transaction is expected to close in November.
The Wilson Sonsini team that advised Socure on the transaction includes:
Client Highlights
10.01.24
Wilson Sonsini Advises PayRange on Investment by Ridgeview Partners
On September 30, 2024, Ridgeview Partners, in partnership with The Baupost Group, announced it has agreed to make a significant strategic growth investment in PayRange, a leading provider of IOT software and payment solutions for unattended retail. Wilson Sonsini Goodrich & Rosati advised PayRange on the transaction.
Client Highlights
12.03.23
Wilson Sonsini Advises Hawaiian Airlines on $1.9 Billion Acquisition by Alaska Airlines
On December 3, 2023, Alaska Airlines and Hawaiian Airlines announced that they had entered into a definitive agreement pursuant to which Alaska Airlines will acquire the holding company of Hawaiian Airlines for $18.00 per share in cash, for a transaction value of approximately $1.9 billion. Wilson Sonsini Goodrich & Rosati advised Hawaiian Airlines on the transaction.
Client Highlights
10.12.22
Wilson Sonsini Advises ForgeRock on $2.3 Billion Acquisition by Thoma Bravo
On October 11, 2022, ForgeRock, a global digital identity leader, and Thoma Bravo, a leading software investment firm, announced that they have entered into a definitive agreement under which Thoma Bravo will acquire ForgeRock in an all-cash transaction valued at $23.25 per share. The offer represents a premium of approximately 53% over ForgeRock’s closing share price on October 10, 2022. Wilson Sonsini Goodrich & Rosati is advising ForgeRock on the transaction.